Contact UsInvestorsCareersMediaContact Us
Investor Relations

LISTING & OTHER INFORMATION​​​​​​​

The Company’s shares are listed at the following Stock Exchanges:
The Bombay Stock Exchange, Mumbai - Security Code: 500680.
The National Stock Exchange of India Ltd. - Security Code: PFIZER EQ.

Pfizer Equity shares were listed with The Bombay Stock Exchange in the year 1966. In January, 1999, Pfizer stock was listed with The National Stock Exchange. Effective May 31, 1999, the Company’s scrip forms part of the Compulsory Demat Segment.

Depositories

The Company has joined both the Depositories viz. National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL). Connectivity to both the Depositories has been established through our Registrars and Transfer Agents, KFin Technologies Limited.

As on 30th June, 2021, 98.85% of the paid-up share capital of the Company representing 4,52,21,109 shares has been dematerialised.

International Securities Identification Number (ISIN)

The Company’s scrips form part of the SEBI’s Compulsory demat segment bearing ISIN No. INE182A01018.

Corporate Identity Number (CIN)

The Company’s CIN, allotted by the Ministry of Corporate Affairs, Government of India,is L24231MH1950PLC008311. The Company is registered at Mumbai in the State of Maharashtra,India.

For any query regarding your dematerialisation, please contact:

KFin Technologies Limited

Unit: Pfizer Limited
Karvy Selenium Tower B, Plot No 31 & 32
Gachibowli, Financial District,
Nanakramguda, Serilingampally
Hyderabad,Telangana – 500032
Tel.No. : 040 6716 2222
Toll Free No.: 1-800-3094-001
Email : einward.ris@kfintech.com
Contact: Mr. MRV Subrahmaniam

Company Details

Board of Directors
Capital History

Financial Information

Financial Information

Policies & Procedures

Model Code of Conduct
Code for Independent Directors
Terms and Conditions of Appointment of - Independent Directors
Whistle Blower/Vigil Mechanism
Policy on Related Party Transactions
Policy on Corporate Social Responsibility
Code for Fair Disclosure
Familiarization Program for Independent - Directors
Policy on criteria for determining materiality of - events
Archival policy for website content
Dividend Distribution Policy
The Blue Book – Summary of Pfizer Polices on - Business Conduct

Analysts Teleconference

Analysts Teleconference

Investor Services

Member Utility
Frequently Asked Questions
Listing & Other Information
Unclaimed Dividend & Shares
Grievance Redressal

Statutory Communications

2021-2022
2020-2021
2019-2020
2018-2019
2017-2018
2016-2017
2015-2016

Compliances under Listing Regulations 2015

Corporate Governance Report​​​​​​​
Shareholding Pattern
Newspaper Advertisements

About UsOur PeopleOur Community EffortsOur ProductsInvestorsCareerMediaAdverse Event ReportingHealth Care ProfessionalsTerms of UsePrivacy PolicyContact UsCopyright © 2002- 2021 Pfizer Inc. All rights reserved.